National Spotlight Features Phio’s Innovative RNAi Technology Platform

April 3, 2024

https://www.globenewswire.com/news-release/2024/04/03/2856816/0/en/National-Spotlight-Features-Phio-s-Innovative-RNAi-Technology-Platform.html

—Program will be airing on PBS with Dennis Quaid in April

—It will also be seen on Fox Business Network

MARLBOROUGH, Mass., April 03, 2024 (GLOBE NEWSWIRE) — Phio Pharmaceuticals Corp. (Nasdaq:PHIO), a clinical stage biotechnology company whose proprietary INTASYL™ siRNA gene silencing technology is designed to make immune cells more effective in killing tumor cells, today announced its INTASYL platform will be the focus of Viewpoint, a national program hosted by Dennis Quaid. The program will air in April on PBS stations across the country.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.